Litcius/Paper detail

Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial

Anna‐Katharina Zoellner, Michael Unterhalt, Stephan Stilgenbauer, Kai Hübel, Catherine Thiéblemont, Bernd Metzner, Max S. Topp, Lorenz Truemper, Christian Schmidt, Kamal Bouabdallah, Jürgen Krauter, Georg Lenz, Jan Dürig, Vibeke Vergote, Kerstin Schäfer‐Eckart, Marc André, Hanneke C. Kluin‐Nelemans, Achiel Van Hoof, Wolfgang Hiddemann, Wolfgang Hiddemann, Martin Dreyling, Eva Hoster

2021The Lancet Haematology53 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMantle cell lymphomaInternal medicinePost-hoc analysisTransplantationHaematopoiesisLymphomaOncologyHematopoietic stem cell transplantationStem cellOpen labelClinical trialSurgeryBiologyGeneticsLymphoma Diagnosis and TreatmentViral-associated cancers and disordersCutaneous lymphoproliferative disorders research
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial | Litcius